Controversies in Persistent (Chronic) Lyme Disease

The Centers for Disease Control and Prevention estimates that more than 300 000 new cases of Lyme disease occur each year in the United States and that 10% to 20% of these patients will remain symptomatic despite receiving appropriate antibiotic therapy. Many elements of the disease are poorly under...

Descripción completa

Detalles Bibliográficos
Autor principal: Maloney, Elizabeth L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2016
Materias:
Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102277/
https://www.ncbi.nlm.nih.gov/pubmed/27755213
http://dx.doi.org/10.1097/NAN.0000000000000195
_version_ 1782466406755860480
author Maloney, Elizabeth L.
author_facet Maloney, Elizabeth L.
author_sort Maloney, Elizabeth L.
collection PubMed
description The Centers for Disease Control and Prevention estimates that more than 300 000 new cases of Lyme disease occur each year in the United States and that 10% to 20% of these patients will remain symptomatic despite receiving appropriate antibiotic therapy. Many elements of the disease are poorly understood and have generated considerable controversy. This paper discusses the medical controversies related to posttreatment manifestations and their potential impact on infusion nurses.
format Online
Article
Text
id pubmed-5102277
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-51022772016-11-22 Controversies in Persistent (Chronic) Lyme Disease Maloney, Elizabeth L. J Infus Nurs Features The Centers for Disease Control and Prevention estimates that more than 300 000 new cases of Lyme disease occur each year in the United States and that 10% to 20% of these patients will remain symptomatic despite receiving appropriate antibiotic therapy. Many elements of the disease are poorly understood and have generated considerable controversy. This paper discusses the medical controversies related to posttreatment manifestations and their potential impact on infusion nurses. Wolters Kluwer Health, Inc. 2016-11 2016-11-17 /pmc/articles/PMC5102277/ /pubmed/27755213 http://dx.doi.org/10.1097/NAN.0000000000000195 Text en © 2016 The Author. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Features
Maloney, Elizabeth L.
Controversies in Persistent (Chronic) Lyme Disease
title Controversies in Persistent (Chronic) Lyme Disease
title_full Controversies in Persistent (Chronic) Lyme Disease
title_fullStr Controversies in Persistent (Chronic) Lyme Disease
title_full_unstemmed Controversies in Persistent (Chronic) Lyme Disease
title_short Controversies in Persistent (Chronic) Lyme Disease
title_sort controversies in persistent (chronic) lyme disease
topic Features
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102277/
https://www.ncbi.nlm.nih.gov/pubmed/27755213
http://dx.doi.org/10.1097/NAN.0000000000000195
work_keys_str_mv AT maloneyelizabethl controversiesinpersistentchroniclymedisease

Ejemplares similares